RQA Insights: The New ICH E6(R3) Guidelines and Their Impact on Clinical Research Recruitment

ICH E6(R3) focuses on risk-based monitoring, tech adoption, and participant-centric trial design.

As recruiters, staying on top of the latest standards in clinical trials is essential, especially with the upcoming changes outlined in the ICH E6(R3) guidelines, which were a major focus at the recent RQA Conference. Here’s a brief overview of what this means for hiring in clinical research:

Risk-Based Approach: The E6(R3) guidelines introduce a “risk-proportionate” focus, encouraging teams to prioritise participant safety and critical data rather than compliance tasks alone. This approach is driving demand for candidates skilled in risk-based monitoring and targeted quality management. 

Embracing Technology and Digital Tools: The new guidelines enable the use of digital and remote monitoring tools such as wearables and decentralised trials. This flexibility creates new roles in digital health and data management, requiring candidates who can blend clinical expertise with tech skills.

Participant-Focused Design: E6(R3) is more participant-centric, aiming to make trials accessible and convenient. This change opens opportunities for roles in patient engagement, remote data collection, and adaptive trial monitoring—ideal for candidates experienced in patient-focused and digital roles.

Alignment with ICH E8(R1): E6(R3) is closely aligned with E8(R1), placing emphasis on Quality by Design (QbD) from the outset. This means candidates with skills in quality-focused trial design will be particularly valuable.

With a full rollout anticipated by 2025, these updated standards are reshaping the clinical trial landscape. Now is an opportune time to connect with candidates who have digital, patient-centred, and quality-focused expertise to lead this next phase in clinical research.

If this is you, or you're interested to hear more. Give me a call on +441293243857